UBS AG is offering $1,353,000 of trigger callable contingent Yield notes linked to the weaker-performing Nasdaq-100 Technology Sector index or S&P 500 Index, with Maturity on September 26, 2029. Investors receive contingent coupons only when both indexes meet specified closing-level conditions, while the notes remain unsecured and uninsured.
Key Highlights
- The notes carry a $9.50 structuring fee per note payable periodically to one or more unaffiliated dealers.
- UBS AG’s notes are due on September 26, 2029.
- The notes are not bank deposits and do not carry FDIC or other government-agency insurance.
The notes are scheduled to mature on September 26, 2029, and are structured as unsubordinated, unsecured Debt obligations of UBS AG.
The notes use the weaker-performing index as the reference for payment terms. A shortfall in either index leaves the contingent coupon condition unsatisfied. The pricing supplement identifies UBS Securities LLC and UBS Investment Bank in connection with the offering. The issue price is $1,000 per note, while proceeds to UBS AG total $1,353,000. The notes are not bank deposits. UBS AG describes the securities as linked to the least-performing index. The documents refer to a prospectus, index supplement and product supplement dated February 6, 2025.
FAQs
Q: What proceeds does UBS AG receive from the notes?
A: UBS AG receives proceeds from the notes, but the article does not state the specific amount.
Q: Who receives the structuring fee for UBS AG’s notes?
A: One or more unaffiliated dealers receive a structuring fee of $9.50 per note. UBS AG will pay that fee periodically.
Q: When are UBS AG’s notes scheduled to mature?
A: The notes are scheduled to mature on September 26, 2029. They are unsubordinated, unsecured debt obligations of UBS AG.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.